MONTREAL--(BUSINESS WIRE)--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable ...
Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis.
The analysis of protein characteristics and interactions is central in drug research. In this web seminar, we will show you how the reliability and robustness of protein characterization can be ...
Talus Bioscience, Inc. ("Talus Bio"), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. ("PRISM") to accelerate the discovery and ...
PRISM BioLab, Co. Ltd. ("PRISM") and Talus Bioscience, Inc. ("Talus Bio") announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback